›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:AnchorAIM® Personalized Treatment of Colorectal Cancer 11 Gene Test
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
AnchorDxType:
Laboratory Developed Test
Related tests:
AnchorAIM® colorectal cancer personalized treatment gene detection and MSI gene detection, for colorectal cancer patients, apply high-throughput sequencing technology to detect the most relevant gene mutations and prognosis-related MSI loci related to colorectal cancer treatment . The treatment of rectal cancer provides genetic information with the most clinical reference value.
Cancer:
Colorectal Cancer
Gene:
APC (APC Regulator Of WNT Signaling Pathway), BRAF (B-raf proto-oncogene), DPYD (Dihydropyrimidine Dehydrogenase), EGFR (Epidermal growth factor receptor), HRAS (Harvey rat sarcoma viral oncogene homolog), KRAS (KRAS proto-oncogene GTPase)
See More ...
APC (APC Regulator Of WNT Signaling Pathway), BRAF (B-raf proto-oncogene), DPYD (Dihydropyrimidine Dehydrogenase), EGFR (Epidermal growth factor receptor), HRAS (Harvey rat sarcoma viral oncogene homolog), KRAS (KRAS proto-oncogene GTPase), MSI (Microsatellite instability), NRAS (Neuroblastoma RAS viral oncogene homolog), PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PTEN (Phosphatase and tensin homolog), TP53 (Tumor protein P53), UGT1A1 (UDP glucuronosyltransferase family 1 member A1)
